• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of Mammalian Target of Rapamycin (mTOR) Signaling by MicroRNA in esophageal cancer

Research Project

Project/Area Number 24591911
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General surgery
Research InstitutionKumamoto University

Principal Investigator

KINOSHITA Kouichi  熊本大学, 医学部附属病院, 非常勤診療医師 (10507792)

Co-Investigator(Kenkyū-buntansha) ISHIMOTO Takatsugu  熊本大学, 医学部附属病院, 非常勤診療医師 (00594889)
HIRASHIMA Koutarou  熊本大学, 医学部附属病院, 非常勤診療医師 (10594468)
HAYASHI Naoko  熊本大学, 医学部附属病院, 非常勤診療医師 (20452899)
IWATSUKI Masaaki  熊本大学, 医学部附属病院, 非常勤診療医師 (50452777)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
KeywordsmicroRNA / mTOR / 食道癌 / replacement therapy / miRNA
Outline of Final Research Achievements

【RNA isolation and microarray profiling in esophageal cancer.】The miRNAs were extracted from formalin-fixed paraffin- embedded (FFPE) esophageal tissues(n=100). Using miRNA microarray, We identified miRNAs with the difference to expression in clinical specimens. Validation of some miRNAs was done by qRT-PCR in tumors and normal tissues. Furthermore, An analysis of overall survival(OS) demonstrated that the low miR-X expression group had a significantly poorer prognosis than the high expression group. Similarly, the positive mTOR group had a signficantly poorer prognosis of OS than the low expression group.
【Regulation of mammalian target of rapamycin (mTOR) signaling by miRNAs in esophageal cancer】Using human esophageal squamous cell carcinoma cell lines, we confirmed relations of some miRNAs and mTOR. After the cells were transfected with miRNA Precursor Molecule using the Lipofectamine transfection reagent, we confirmed an inverse correlation between some miRNAs and mTOR in vitro.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (4 results)

All 2014 2012

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (2 results)

  • [Journal Article] Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.2014

    • Author(s)
      S. Ishikawa, H. Hayashi, K. Kinoshita, M. Abe, H. Kuroki, R. Tokunaga, S. Tomiyasu, H. Tanaka, H. Sugita, T. Arita, Y. Yagi, M. Watanabe, M. Hirotaand H. Baba
    • Journal Title

      Internationa Journal of Cancer

      Volume: Epub ahead of print Issue: 11 Pages: 2528-36

    • DOI

      10.1002/ijc.28672

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma2012

    • Author(s)
      K.Hirashima, et al.
    • Journal Title

      Brithish journal of cancer

      Volume: 106 Issue: 5 Pages: 876-882

    • DOI

      10.1038/bjc.2012.36

    • NAID

      120005148224

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] TAZ (WWTR1), a key transcription co-activator of hippo-pathway, promotes hepatocellular carcinoma progression via PI3K/Akt/mTOR pathway2014

    • Author(s)
      Hayashi H
    • Organizer
      AACR Annual Meeting 2014
    • Place of Presentation
      San Diego, California
    • Year and Date
      2014-04-05 – 2014-04-09
    • Related Report
      2014 Annual Research Report
  • [Presentation] 食道癌の発育進展におけるmTORの関与とmiR-99aによる制御2012

    • Author(s)
      木下浩一
    • Organizer
      第112回日本外科学会
    • Place of Presentation
      幕張メッセ
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi